LEADER 03096nam 2200613Ia 450 001 9910453446503321 005 20200520144314.0 010 $a3-8349-8132-X 024 7 $a10.1007/978-3-8349-8132-5 035 $a(CKB)1000000000545951 035 $a(EBL)751098 035 $a(OCoLC)828796470 035 $a(SSID)ssj0000630925 035 $a(PQKBManifestationID)11404051 035 $a(PQKBTitleCode)TC0000630925 035 $a(PQKBWorkID)10747531 035 $a(PQKB)11078958 035 $a(DE-He213)978-3-8349-8132-5 035 $a(MiAaPQ)EBC751098 035 $a(PPN)132862174 035 $a(Au-PeEL)EBL751098 035 $a(CaPaEBR)ebr10274766 035 $a(CaONFJC)MIL195550 035 $a(EXLCZ)991000000000545951 100 $a20081215d2008 uy 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt 182 $cc 183 $acr 200 10$aCorporate sustainability management in the energy sector$b[electronic resource] $ean empirical contingency approach /$fby Oliver Salzmann 205 $a1st ed. 2008. 210 $aWiesbaden $cGabler Verlag / GWV Fachverlage GmbH, Wiesbaden$d2008 215 $a1 online resource (371 p.) 300 $aDescription based upon print version of record. 311 $a3-8349-0854-1 320 $aIncludes bibliography. 327 $aTheoretical foundation and concepts -- Review of empirical literature -- Conceptual rationale and research questions -- Method -- Sector characteristics -- Data collected -- Empirical evidence -- Synopsis. 330 $aCorporate social responsibility, sustainability, and citizenship are terms that often evoke considerable scepticism and cynicism, particularly in civil society. Much needed sector-specific and comparative research, which could facilitate a more fact-oriented debate, is still missing from the literature. The present study aims to fill this gap by presenting data collected from two groups of managers, namely sustainability experts and non-sustainability experts, from two different industry sectors (integrated oil and gas vs. electric utilities) and several geographical regions. Oliver Salzmann provides a comprehensive view on corporate sustainability management in companies such as Shell and RWE and investigates the key social and environmental issues driving the energy sector. The author analyses the influence which stakeholder pressure exercises on energy companies and their efforts to become more responsive. Moreover, he develops a model for strategic, thus profit-oriented, corporate sustainability management. 606 $aSustainable development 606 $aEnergy industries$xManagement 608 $aElectronic books. 615 0$aSustainable development. 615 0$aEnergy industries$xManagement. 676 $a658.2 676 $a658.26 700 $aSalzmann$b Oliver$0918679 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910453446503321 996 $aCorporate sustainability management in the energy sector$92060254 997 $aUNINA LEADER 03041oam 2200469 450 001 9910300331403321 005 20190911112727.0 010 $a88-470-5385-4 024 7 $a10.1007/978-88-470-5385-4 035 $a(OCoLC)876298384 035 $a(MiFhGG)GVRL6VTI 035 $a(EXLCZ)993710000000075604 100 $a20130821d2014 uy 0 101 0 $aeng 135 $aurun|---uuuua 181 $ctxt 182 $cc 183 $acr 200 00$aImaging in clinical oncology /$fAthanasios D. Gouliamos, John A. Andreou, Paris A. Kosmidis, editors 205 $a1st ed. 2014. 210 1$aMilan :$cSpringer,$d2014. 215 $a1 online resource (xviii, 609 pages) $cillustrations (some color) 225 0 $aGale eBooks 300 $aDescription based upon print version of record. 311 $a88-470-5384-6 320 $aIncludes bibliographical references. 327 $aI. Introduction.- II. Bone and Soft Tissue Tumors -- III.CNS Tumors .-IV. Lung Cancer -- V. Head and Neck Cancer -- VI. Lymphomas -- VII. Gynecologic Cancer -- VIII. Breast Cancer -- IX. Gastrointestinal Cancer -- Esophagus, Stomach -- Solid Organs (Liver, Pancreas) -- Peritoneal Cavity -- Large Bowel -- X. Neuroendocrine Tumors -- XI. Urogenital Cancer -- Adrenal Cancer -- Renal Cancer -- Urothelial Cancer -- Testicular Cancer -- Prostate cancer -- XII. Melanoma. 330 $aThis encompassing book is designed to contribute to a teamwork approach to imaging among radiologists and clinical oncologists that will ensure the best possible outcomes for patients. All of the currently available imaging modalities of relevance in clinical oncology are covered, and the presentation of a broad spectrum of oncologic diseases (of most organ systems) on these modalities is discussed and illustrated. The role of multiparametric and multimodality imaging approaches providing both morphologic and functional information is considered in detail, and careful attention is paid to the latest developments in higher field (3T) MR imaging and advanced MR techniques such as diffusion-weighted imaging, diffusion tensor imaging, perfusion-weighted imaging and spectroscopy. The major challenge of incorporating progress in quantitative imaging technology into radiotherapy treatment planning, guidance, and monitoring is also addressed.   This book will assist in refining the treatment approach in various oncologic diseases and organ systems based on specific imaging features. It will be of value to radiologists, oncologists, and other medical professionals involved in the diagnosis and treatment of oncology patients. 606 $aCancer$xImaging 606 $aOncology 615 0$aCancer$xImaging. 615 0$aOncology. 676 $a616.9940754 702 $aGouliamos$b Athanasios D. 702 $aAndreou$b John A. 702 $aKosmidis$b Paris A. 801 0$bMiFhGG 801 1$bMiFhGG 906 $aBOOK 912 $a9910300331403321 996 $aImaging in Clinical Oncology$91521751 997 $aUNINA